This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! Check out the community’s predictions down below and be sure to follow along as we share more 2025 Health IT Predictions !
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! Check out the community’s predictions down below and be sure to follow along as we share more 2025 Health IT Predictions ! What do you think will happen for AI Tools in 2025?
Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drugdevelopment. Petra Jantzer, Ph.D.,
Read more… 2025 Health IT Predictions: Pharma. On the pharma front, expect an emphasis on AI for inventory management and targeted drugdevelopment , plus a shake-up in the market for weight-loss drugs. This should give them a competitive advantage, Cagle said.
As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. Drugdevelopers can use these tools to inform routine information-discovery tasks that would require much more time for humans to execute, including benefits-risk evaluation and safety assessments.
This is the pathway toward achieving human digital twins, dynamic models that not only reflect and allow health monitoring but also enhance patient stratification, improve the success rates of drugdevelopment programs, and enable treatment testing before application.
Artificial intelligence (AI) holds great promise to dramatically improve clinical outcomes for patients, but in a perverse twist, AI algorithms that are used to improve drugdevelopment and support healthcare don’t just highlight social inequities — they may ultimately exacerbate them. A lingering […].
In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs. See more on that recommendation, and subsequent social media frenzy, here on Health Populi ).
In our interview, Gil emphasizes the critical role of AI in expediting the discovery of new drugs, citing the lengthy and costly nature of traditional drugdevelopment processes. However, with AI-driven approaches, Aion Labs is paving the way for a paradigm shift in drug discovery.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
The companies are evolving in many ways, including stepping outside drugdevelopment to tryout digital treatments and using lessons from the COVID-19 pandemic to rethink production and clinical trials. Where are pharma companies investing their windfall profits?
Curebase today announced $15M in Series A funding to continue developing its decentralized clinical trial software platform and virtual research site capabilities, powering research where any patient, anywhere, can be part of clinical trials at home and with their own doctor.
New healthcare AI and Machine Learning research conducted by Healthcare IT Today suggests that many industry leaders are serious about adopting healthcare AI and machine learning tools and what’s more, that these technologies are being used as part of mission-critical efforts rather than one-off pilot tests.
The FDA issued a series of four patient-focused drugdevelopment (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.
As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, performance, and scalability of computational pathology analyses for drugdevelopment and diagnostics.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
In this video, he describes other ways that AI can make drugdevelopment more efficient. At the design stage, a drug company can run millions of simulations to determine where risks lie and what parameters are most promising.
That doesn’t just lead to faster trials, it changes the way companies can think about drugdevelopment going from waterfall big bets to agile research.” . “We’re fixing that with a new paradigm for running trials underpinned by technology.
Here they are producing more accurate and efficient tools for drugdevelopment. The biotherapeutics monitoring equipment from 908 Devices illustrates the positive role technology—sensitive measuring devices, analytics, and automation—can play in medicine.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
Focus on Digital Health and AI: European companies will invest in digital health startups and AI-driven solutions to improve patient outcomes and operational efficiency. Consolidation in Specific Segments: M&A activity will be concentrated in areas like telemedicine, medical devices, and health IT. Subscribe Today!
Nair suggested that AI can make it easier to manage health care regulations, on which a hospital spends 8 million dollars a year on average. He also said that the benefits go beyond doctors; for instance, care coordinators can be more efficient and AI can help drugdevelopment.
This ML-driven adaptive process can significantly accelerate the clinical drugdevelopment process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials.
The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drugdevelopment in oncology. In conjunction, COTA announced it has raised additional capital from existing investors. COTA Adds Emerging Types of Data to Oncology Real-World Data Platform.
AllStripes has developed a technology platform that generates research-ready evidence to accelerate rare disease research and drugdevelopment, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data.
“We are excited to announce this funding that supports our mission to enhance the drugdevelopment pathway from discovery through commercialization,” said Eran Seger, Co-Founder and CEO at Protai. “I We look forward to scaling our organization and its important work towards revolutionizing the drugdevelopment landscape.” “Our
From 3D-printed limbs to surgical robots , health providers have implemented AI to find creative treatment solutions for complex medical issues. We’re already seeing the benefits of AI-infused research in pharmaceuticals and drugdevelopment.
Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI Leverages Proprietary AI, Generative Computational Chemistry, and Best-in-Class Biology to Cut DrugDevelopment Timelines and Costs, Transforming Cancer and Rare Disease Treatments Company Raises $24.6
But returning to Erin Moore’s point, how do we get researchers, clinicians, and industry engaged to listen to patients in clinical trial design, pharma/biotech drugdevelopment and health tech capability? She was the patient keynote speaker at DPHARM 2021 and is a HIMSS Digital Health Influencer.
Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!
Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drugdevelopment and discovery process. One area where the need for diversity has never been greater is clinical trials.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Email lloyd@nelsonadvisors.co.uk Subscribe Today! Buy, build or partner?
Traditional drugdevelopment timelines and regulatory hurdles can stifle the development of drugs for rare conditions, but Moonshots for Cancer’s Zachary Landman, MD said decentralized clinical trials and repurposing existing medicines for new conditions should help patients get the therapies they need.
Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. Digital transformation is the topic du jour in healthcare today.
.” “The massive proliferation of patient data, coupled with advances in analytical methods, can enable providers and pharmaceutical companies to transform clinical decision-making, optimize drugdevelopment, and ultimately improve patient outcomes,” said Tyler Schinto from Presidio Ventures.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
.” Prognos Health’s platform is used by over 70 life sciences customers to accelerate the development of new drugs, improve the safety and efficacy of existing drugs, and identify new patient populations that may benefit from specific treatments.
The Office of the National Coordinator for Health IT has some money for you. The latest Leading Edge Acceleration Projects (LEAP) in Health IT funding opportunity will award grants to applicants working in two areas.
Redi.Health recently forged partnerships with several healthcare heavyweights like GoodRx and ScriptDrop, as well as a collaboration with Labcorp that integrates the Labcorp DrugDevelopment Patient Access Solutions with Redi.Health’s digital support platform to more seamlessly connect patients and providers. .
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!
In the context of healthtech and digital health, it means a company initially targets consumers (B2C), builds a strong user base, and then leverages this consumer adoption to attract businesses (B2B), such as insurers, employers, or healthcare providers. Accelerate drugdevelopment: Speed up the clinical trial process and reduce costs.
We are particularly excited about the ability of these tools to drive more efficient and faster drugdevelopment processes in the biopharma industry.” “The “We believe Flywheel’s unique software solutions enable the smarter use and interpretation of the vast amounts of information associated with large numbers of medical imaging scans.
Biopharma Innovation and DrugDevelopment: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates. Subscribe Today!
Poor quality data leads to drugdevelopment being delayed, patients being misdiagnosed and inaccurate scientific conclusions. “Data quality has become one of the biggest problems in the healthcare industry – one that has significant consequences,” said Cornerstone Co-founder and CEO Michael Elashoff.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content